Anti-MST1R antibodies and uses thereof

Details for Australian Patent Application No. 2010214301 (hide)

Owner Daiichi Sankyo Company, Limited

Inventors Kawaida, Reimi; Ohtsuka, Toshiaki; Agatsuma, Toshinori; Rodley, Philip; Miller, Sandra; Schubert, Ulrike

Agent Davies Collison Cave

Pub. Number AU-A-2010214301

PCT Pub. Number WO2010/093055

Priority 61/151,411 10.02.09 US

Filing date 10 February 2010

Wipo publication date 19 August 2010

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/093055 Priority application(s): WO2010/093055

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010214305-Method for producing phenylacetamide compound

2010214203-Washing method and washing machine